Form 4 for EXEL EXELIXIS, INC.
Accepted 2025-10-10 00:00:00 ET · period of report 2025-10-08 · accession 0000939767-25-000118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-10 | 2025-10-08 | EXEL | Aftab Dana | EVP, Research, Development | A - Grant | $0.00 | +50.7K | 713.2K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-08 | A | A | 50,673 | $0.00 | 713,161 | D | — | — | (F1) Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on November 15, 2026 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each November 15th until fully vested. (F2) Includes 431,306 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. |